Ying Luo
Independent Non-Executive DirectorMs. Ying Luo, also known as Laura, CFA, CPA is Independent Non-Executive Director at Tianjin Port Development Holdings Limited from March 27, 2023. She is Partner of First Rice Capital. She serves as an Independent Non-Executive Director at China Medical System Holdings Limited since March 31, 2020. She has been Independent Non-Executive Director at Central China New Life Limited since April 29, 2020. She served as the Head of Hong Kong China Equities and a Portfolio Manager at Baring Asset Management Limited since September 12, 2013. Ms. Luo was responsible for managing the Hong Kong China equities team at Baring Asset Management. She had been a Portfolio Manager at The Baring International Umbrella Fund - Baring Hong Kong China Fund since September 12, 2013. She served as a Portfolio Manager at Baring Asset Management (Asia) Limited. She has experience of researching and investing in Hong Kong China equities. Previously, Ms. Luo served as a Portfolio Manager at Schroder Investment Management (Hong Kong) Limited. Prior to that, Ms. Luo was employed at Morgan Stanley. Ms. Luo served as an Analyst at Societe Generale Cross Asset Research. She served as a Portfolio Manager at MML Series Investment Fund II - MML China Fund. She served as Equity Analyst at Morgan Stanley, Research Division. She served as a Fund Manager at Schroder International Selection Fund SICAV - China Opportunities. She has experience in the investment field. She served in various global investment banks and asset management firms. Ms. Luo is currently an investment Director of GL China Equity HK Management Limited. She was previously a consultant of GL Capital Management Limited. Ms. Luo is currently an Independent Non-Executive Director of Central China New Life Limited and China Medical System Holdings Limited, both being companies listed on The Stock Exchange of Hong Kong Limited. From 1995 to 1999, Ms. Luo worked in various investment banks including Goldman Sachs (Asia) L. L.C. and Morgan Stanley Dean Witter Asia Limited as a research Analyst. From November 1999 to July 2001, she was the Head of China research of the research department of SG Securities (HK) Limited. She has Master's of Business Administration from University of Toronto in 1991 and Bachelor's of Arts in International Economics from Peking University in 1987.
Positions
- Company NameCentral China New Life LimitedStock Code09983PositionIndependent Non-Executive Director
- Company NameChina Medical System Holdings LimitedStock Code00867PositionIndependent Non-Executive DirectorRelated SecuritiesColleagues
- KLKong LamFounder, Chairman, CEO & President
- YCYanling ChenCFO, VP & Executive Director
- LMLieyi MaGeneral Manager of the Operations & Management Center of the Group
- LYLiu YueDirector of Investor Relations
- SWSanyan WuDirector of Legal Department & Company Secretary
- CSChong Shun LeungIndependent Non-Executive Director
- YLYing LuoIndependent Non-Executive Director
- CFChing FungIndependent Non-Executive Director
